BIKEN Endowed Department of Dengue Vaccine Development, Mahidol University, 420/6 Ratchawithi Road, Ratchahewi, Bangkok 10440, Thailand.
Expert Rev Vaccines. 2013 Aug;12(8):871-3. doi: 10.1586/14760584.2013.814828. Epub 2013 Aug 14.
Japanese encephalitis (JE) virus requires dissemination within the host via the circulation for disease development. Thus, a serum-neutralizing antibody is an effective factor to protect against disease. Current licensed JE vaccines induce neutralizing antibodies and titers of 1:10 or higher are the recommended immunological correlate of protection. In this paper, the authors demonstrated, using a highly susceptible knockout mouse model, that memory B cells are required for disease protection and that detectable neutralizing antibodies at the time of challenge are dispensable. The authors proposes that the extent of memory B cells would be an alternative and better immunological correlate for evaluating the efficacy of JE vaccine candidates in clinical trials.
日本脑炎 (JE) 病毒需要在宿主内通过循环传播才能引起疾病。因此,血清中和抗体是预防疾病的有效因素。目前,许可的 JE 疫苗会诱导产生中和抗体,并且 1:10 或更高的滴度被推荐为保护性免疫的相关指标。在本文中,作者使用高度易感的基因敲除小鼠模型证明,记忆 B 细胞是疾病保护所必需的,而在挑战时可检测到的中和抗体则是可有可无的。作者提出,记忆 B 细胞的数量将是评估 JE 候选疫苗在临床试验中的疗效的替代和更好的免疫相关性指标。